← back to search

Hui Liu

Shenzhen Technology University · CN
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Chronic Myeloid Leukemia Treatments, and Acute Lymphoblastic Leukemia research.
h-index
29
citations
4,326
works
363
NIH funding
primary concept
email

Recent publications

Over 20% Efficient Water‐Based Layer‐by‐Layer Organic Solar Cells with High Thickness Tolerance Enabled by Surfactant Promoted Electrostatic Interaction
Advanced Materials 2025cited by 15position: middledoi
Novel mechanism of fluoride induced cardiovascular system injury by regulating p53/miR200c-3p during endothelial dysfunction
Environmental Research 2025cited by 8position: middledoi
Frontiers in high entropy alloys and high entropy functional materials
Rare Metals 2024cited by 132position: middledoi
A nonlinear visco-elasto-plastic creep model for sandstone considering creep initiation conditions and experimental verification
Mechanics of Time-Dependent Materials 2024cited by 10position: middledoi
A sucrose ferulate cycle linchpin for feruloylation of arabinoxylans in plant commelinids
Nature Plants 2024cited by 9position: middledoi
Relationship between timing of coffee and tea consumption with mortality (total, cardiovascular disease and diabetes) in people with diabetes: the U.S. National Health and Nutrition Examination Survey, 2003–2014
BMC Medicine 2024cited by 9position: middledoi
Metabolome and Transcriptome Analyses Reveal Metabolomic Variations and Key Transcription Factors Involved in Lipid Biosynthesis During Seed Development in Carya illinoinensis
International Journal of Molecular Sciences 2024cited by 3position: middledoi
Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts
BMC Cancer 2024cited by 1position: middledoi
ncStem: a comprehensive resource of curated and predicted ncRNAs in cancer stemness
Database 2024cited by 1position: firstdoi
Long-term follow-up of zimberelimab in relapsed or refractory classic Hodgkin lymphoma: Insights from the phase Ⅱ YH-S001-04 clinical trial
Leukemia Research 2024cited by 0position: middledoi
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
The Lancet Haematology 2023cited by 66position: middledoi
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
Blood Advances 2023cited by 18position: middledoi
The value of breast ultrafast dynamic contrast-enhanced magnetic resonance imaging in diagnosing axillary lymph node metastasis in mass-type invasive ductal carcinoma of the breast
Quantitative Imaging in Medicine and Surgery 2023cited by 0position: middledoi
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial
Journal of Clinical Oncology 2022cited by 51position: middledoi
A Novel Mutation of Transferrin Receptor 2 in a Chinese Pedigree With Type 3 Hemochromatosis: A Case Report
Frontiers in Genetics 2022cited by 4position: middledoi
Patient‐Specific Organoid and Organ‐on‐a‐Chip: 3D Cell‐Culture Meets 3D Printing and Numerical Simulation
Advanced Biology 2021cited by 85position: middledoi
Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study
European Journal of Cancer 2021cited by 49position: middledoi
Changes in the structure and digestibility of myoglobin treated with sodium chloride
Food Chemistry 2021cited by 32position: firstdoi
Comparison of long-term outcomes between Chinese peritoneal dialysis patients with and without diabetes: A 10-year cohort study
Journal of Diabetes and its Complications 2021cited by 3position: middledoi
Outcomes of icotinib combined with concurrent chemoradiotherapy in locally advanced cervical cancer
Neoplasma 2021cited by 3position: middledoi
Iron phthalocyanine with coordination induced electronic localization to boost oxygen reduction reaction
Nature Communications 2020cited by 652position: middledoi
Anti-aging effect of the combination of Bifidobacterium longum and B. animalis in a d-galactose-treated mice
Journal of Functional Foods 2020cited by 40position: middledoi
[Acupuncture Combined with Acupoint Application Improves Symptoms, Daily Life Quality and Lung Function in Chronic Obstructive Pulmonary Disease Patients during Acute Exacerbation].
PubMed 2016cited by 9position: first
Geldanamycin mediates the apoptosis of gastric carcinoma cells through inhibition of EphA2 protein expression
Oncology Reports 2014cited by 6position: middledoi
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
Journal of Hematology & Oncology 2013cited by 106position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Qifa Liu · University of Science and Technology of China3 papers (2013–2023)Fen Huang · Sun Yat-sen University3 papers (2013–2023)Zhiping Fan · China-Japan Friendship Hospital3 papers (2013–2023)Jing Sun · Jiangnan University3 papers (2013–2023)Li Xuan · Southern Medical University2 papers (2022–2023)Sanfang Tu · Zhujiang Hospital2 papers (2013–2023)Ren Lin · Xiangya Hospital Central South University2 papers (2022–2023)Lan Deng · Tianjin Agricultural University2 papers (2022–2023)Hongsheng Zhou · Dalian Medical University2 papers (2013–2022)Xiaodan Luo · Army Medical University2 papers (2022–2023)Xudong Li · Union Hospital2 papers (2022–2023)Na Xu · Tongji Hospital2 papers (2022–2023)Xinquan Liang · Shandong Provincial QianFoShan Hospital2 papers (2022–2023)Yajing Xu · South China University of Technology2 papers (2022–2023)Pengcheng Shi · Chinese PLA General Hospital2 papers (2022–2023) · 1 papers (2024–2024)Nan Zhang · The First Affiliated Hospital, Sun Yat-sen University1 papers (2024–2024)Qiaoyu Wang · Harbin Medical University1 papers (2025–2025) · 1 papers (2022–2022)Yiyang Lin · Shanghai University1 papers (2020–2020)